Jade Biosciences (JBIO) Institutional Ownership $9.22 -0.25 (-2.64%) As of 11:06 AM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Jade Biosciences (NASDAQ:JBIO)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$157.40KNumber ofInstitutional Sellers(last 12 months)0 Get JBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Jade Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Jade Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/18/2025 Deltec Asset Management LLC15,756$157K0.0%N/A1.876% (Data available from 1/1/2016 forward) JBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JBIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Jade Biosciences shares: Deltec Asset Management LLC ($157K).Learn more on Jade Biosciences' institutional investors. Which institutional investors have been buying Jade Biosciences' stock? The following institutional investors have purchased Jade Biosciences' stock in the last 24 months: Deltec Asset Management LLC ($15.76K). How much institutional buying is happening at Jade Biosciences? Institutional investors have bought a total of 15,756 shares in the last 24 months. This purchase volume represents approximately $157.40K in transactions. Related Companies Enlivex Therapeutics Institutional Ownership Generation Bio Institutional Ownership Dyadic International Institutional Ownership Ovid Therapeutics Institutional Ownership Dare Bioscience Institutional Ownership NeuroSense Therapeutics Institutional Ownership MIRA Pharmaceuticals Institutional Ownership Tempest Therapeutics Institutional Ownership FibroBiologics Institutional Ownership ALX Oncology Institutional Ownership This page (NASDAQ:JBIO) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
